Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2018
Pharma News, 2018
Gates backs gene technologies in fight to end malaria
LONDON, April 18 (Reuters) - Gene-editing technologies that alter mosquitoes’ DNA could prove critical in the fight against malaria, Bill Gates said on Wednesday, and ethical concerns should...
Advent International enters into exclusive negotiations to acquire Zentiva, Sanofi’s European generics business
PARIS – 17 April 2018 – Advent International (“Advent”) and Sanofi have entered into exclusive negotiations under which Advent would acquire Zentiva, Sanofi’s European generics busin...
World Hemophilia Day 2018: Sharing Knowledge Makes Us Stronger
On April 17, 2018, the global bleeding disorders community and the World Federation of Hemophilia (WFH) will come together to promote and encourage Sharing Knowledge and the role it plays i...
Karyopharm’s Selinexor Receives Fast Track Designation from FDA for the Treatment of Patients with Penta-Refractory Multiple Myeloma
NEWTON, Mass.
vTv Therapeutics Announces Topline Results from the First STEADFAST Phase 3 Study Evaluating Azeliragon in People with Mild Alzheimer’s Disease
HIGH POINT, N.
Mylan seeks deal for German Merck's consumer products unit: sources
FRANKFURT/NEW YORK (Reuters) - Generic drug maker Mylan NV is in advanced discussions to acquire Merck KGaA’s consumer health business after other bidders failed to meet the German company...
Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles
LONDON (Reuters) - Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan’s Takeda Pharmaceutical, is selling its oncology business to unlisted Frenc...
Hanmi Pharma gives up on development of lung cancer drug Olita
South Korean pharmaceutical firm Hanmi Pharmaceutical is expected to cease development of Olita, a lung cancer treatment, following its slow progress in clinical trials and cancellation of licensing d...
Good cholesterol may increase the risk of gastro, pneumonia: Study
London.
US FDA approves first AI device to detect diabetic eye disease
Washington.
Eating berries may prevent cancer: Study
London.
Sanofi to invest €350 million in Canadian vaccine facility
PARIS – April 12, 2018 – Sanofi is investing €350 million (CAD $500 million) for the construction of a new state-of-the-art vaccine manufacturing facility at the Sanofi Pasteur Canadian ...
47
48
49
50
51
52
53
54
55
